Carregant...

The Second Life of Methylarginines as Cardiovascular Targets

Endogenous methylarginines were proposed as cardiovascular risk factors more than two decades ago, however, so far, this knowledge has not led to the development of novel therapeutic approaches. The initial studies were primarily focused on the endogenous inhibitors of nitric oxide synthases asymmet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Jarzebska, Natalia, Mangoni, Arduino A., Martens-Lobenhoffer, Jens, Bode-Böger, Stefanie M., Rodionov, Roman N.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6769906/
https://ncbi.nlm.nih.gov/pubmed/31533264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20184592
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!